Literature DB >> 9203727

Comparison of a monoclonal antibody-based IgM capture ELISA with a neutralization assay for assessing response to trivalent oral poliovirus vaccine.

H E Gary1, C Freeman, S Peñaranda, K Maher, L Anderson, M A Pallansch.   

Abstract

Monoclone-based IgM capture ELISAs were developed for each of the three poliovirus serotypes and compared with a neutralization assay for detecting response to trivalent oral poliovirus vaccine among 224 infants. The IgM-based response rates were significantly higher than the neutralizing antibody-based rates: 95% versus 83% to poliovirus type 1, 99% versus 94% to poliovirus type 2, and 89% versus 59% to poliovirus type 3. IgM responses to the first vaccine dose were significantly associated between serotypes, suggesting that some of the discordance may reflect a heterotypic IgM response. When the response rates in 4 vaccine formulation groups were compared, group differences using the two assays were similar for poliovirus types 1 and 2 but not for type 3. Therefore, IgM results using these assays may not be adequate substitutes for neutralizing antibody results when determining vaccine response.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9203727     DOI: 10.1093/infdis/175.supplement_1.s264

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  3 in total

1.  Combined cell culture enzyme-linked immunosorbent assay for quantification of poliovirus neutralization- relevant antibodies.

Authors:  A F Wahby
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

2.  Neonatal vitamin A supplementation and immune responses to oral polio vaccine in Zimbabwean infants.

Authors:  James A Church; Sandra Rukobo; Margaret Govha; Marya P Carmolli; Sean A Diehl; Bernard Chasekwa; Robert Ntozini; Kuda Mutasa; Jean H Humphrey; Beth D Kirkpatrick; Andrew J Prendergast
Journal:  Trans R Soc Trop Med Hyg       Date:  2019-03-01       Impact factor: 2.184

3.  Immune responses to oral poliovirus vaccine in HIV-exposed uninfected Zimbabwean infants.

Authors:  James A Church; Sandra Rukobo; Margaret Govha; Marya P Carmolli; Sean A Diehl; Bernard Chasekwa; Robert Ntozini; Kuda Mutasa; Jean H Humphrey; Beth D Kirkpatrick; Andrew J Prendergast
Journal:  Hum Vaccin Immunother       Date:  2017-08-31       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.